United States · FDA National Drug Code directory
BUDESONIDE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 45802-627_ad4a68e7-9200-4f05-8058-714d5d8900f8
- Product NDC
- 45802-627
- Form
- AEROSOL, FOAM
- Composition / generic term
- budesonide
- Labeler
- Padagis Israel Pharmaceuticals Ltd
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230417
- Source listing expiry
- 20261231
Source-listed ingredients
- BUDESONIDE — 2 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 2 CANISTER in 1 CARTON (45802-627-86) / 1 AEROSOL, FOAM in 1 CANISTER (45802-627-01) · 45802-627-86
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →